Corticoides en la enfermedad inflamatoria intestinal: ¿siguen siendo una opción terapéutica?

Rodrigo Quera, Paulina Núñez, Beatriz Sicilia, Lilian Flores, Fernando Gomollón*

*Autor correspondiente de este trabajo

Resultado de la investigación: Contribución a una revistaArtículo de revisiónrevisión exhaustiva


Despite the development and incorporation of new therapeutic strategies, such as biologic therapy and small molecules, corticosteroids still play an important role in inducting inflammatory bowel diseases (IBD) remission. Variables like indicating the right doses at the right time, in adequate intervals, the security of these drugs and the pharmacological alternatives available must be considered by the providers when they are indicated to patients with IBD. Although the use of corticosteroids is considered as a marker of quality of care in patients with IBD, the use of these drugs in the clinical practice of IBD is far from being the correct one. This review article is not intended to be just a classic review of the indications for corticosteroids. Here we explain the scenarios in which, in our opinion, steroids would not be an appropriate option for our patients, as well as the most frequent mistakes we make in our daily practice when using them.

Título traducido de la contribuciónCorticosteroids in inflammatory bowel disease: Are they still a therapeutic option?
Idioma originalEspañol
PublicaciónGastroenterologia y Hepatologia
EstadoAceptada/en prensa - 2022

Nota bibliográfica

Publisher Copyright:
© 2022 The Author(s)

Palabras clave

  • Budesonide
  • Corticosteroids
  • Health care
  • Inflammatory bowel disease
  • Steroids
  • Treatment


Profundice en los temas de investigación de 'Corticoides en la enfermedad inflamatoria intestinal: ¿siguen siendo una opción terapéutica?'. En conjunto forman una huella única.

Citar esto